Systemic complications of acromegaly: epidemiology, pathogenesis, and management.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Endocrine reviews

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/ER.2002-0022PMID 14769829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypoxemia and pulmonary function in acromegaly.

  2015influential reference
• Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I.

  2009influential reference
• Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984.

  2009cited by this paper
• A hyperkinetic heart in uncomplicated active acromegaly. Explanation of hypertension in acromegalic patients?

  2009cited by this paper
• Atrial natriuretic factor in patients with acromegaly

  2006influential reference
• Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine

  2005cited by this paper
• Expression of IGF-I and IGF-II mRNA in breast tissue

  2005cited by this paper
• Carpal tunnel syndrome and acromegaly

  2005cited by this paper
• Type 1 IGF receptor in human breast diseases

  2005cited by this paper
• The insulin-like growth factor system in advanced breast cancer.

  2004cited by this paper
• Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

  2003cited by this paper
• Insulin action on protein metabolism in acromegalic patients.

  2003cited by this paper
• Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study.

  2003cited by this paper
• Reversal of acromegalic cardiomyopathy in young but not in middle‐aged patients after 12 months of treatment with the depot long‐acting somatostatin analogue octreotide

  2003influential reference
• High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study.

  2003cited by this paper
• Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly.

  2003cited by this paper
• Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.

  2003cited by this paper
• Cardiovascular function in acromegaly.

  2003influential reference
• Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas.

  2002cited by this paper
• Growth hormone receptor antagonist improves insulin resistance in acromegaly.

  2002cited by this paper
• Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.

  2002cited by this paper
• Gender and age influence the relationship between serum GH and IGF‐I in patients with acromegaly

  2002cited by this paper
• Comments on E. Giovannucci, "Insulin, insulin-like growth factors and colon cancer: a review of the evidence".

  2002cited by this paper
• Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.

  2002cited by this paper
• New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy

  2002cited by this paper
• Prevalence of thyroid diseases in patients with acromegaly: results of an Italian Multi-center Study

  2002cited by this paper
• Cardiovascular consequences of early-onset growth hormone excess.

  2002influential reference
• Serum leptin levels in acromegaly--a significant role for adipose tissue and fasting insulin/glucose ratio.

  2002cited by this paper
• Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

  2002cited by this paper
• [Sleep apnea-hypopnea syndrome].

  2002influential reference
• Submandibular salivary gland volume is increased in patients with acromegaly

  2002cited by this paper
• Modifications of the cardiovascular system with aging.

  2002cited by this paper
• Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study

  2002cited by this paper
• Overexpression of the insulin‐like growth factor I receptor in human colon carcinomas

  2002cited by this paper
• Serum lipoprotein changes following IGF‐I normalization using a growth hormone receptor antagonist in acromegaly

  2002cited by this paper
• Modifications of the cardiovascular system with aging.

  2002cited by this paper
• Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly.

  2002influential reference
• Effects of two different somatostatin analogs on glucose tolerance in acromegaly

  2002cited by this paper
• Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

  2002cited by this paper
• Early vascular alterations in acromegaly.

  2002cited by this paper
• Gender- and age-related differences in the endocrine parameters of acromegaly

  2002cited by this paper
• Acromegaly and cancer risk: a cohort study in Sweden and Denmark

  2002cited by this paper
• Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.

  2002cited by this paper
• Incidence of sleep apnea in a presumably healthy working population: a significant relationship with excessive daytime sleepiness.

  2002cited by this paper
• Local Expression of Insulin-Like Growth Factor-I Affects Angiogenesis in Colorectal Cancer

  2002cited by this paper
• Co-expression of GH and GHR isoforms in prostate cancer cell lines.

  2002cited by this paper
• Colonoscopic miss rates determined by direct comparison of colonoscopy with colon resection specimens

  2002cited by this paper
• Ventilation threshold as a measure of impaired physical performance in adults with growth hormone excess

  2002cited by this paper
• Peroxisome proliferator activated receptor gamma expression is reduced in the colonic mucosa of acromegalic patients.

  2002cited by this paper
• Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients.

  2002cited by this paper
• Characterization of premature atherosclerosis of carotid arteries in acromegalic patients

  2001cited by this paper
• Bone mineral density in acromegaly: Does growth hormone excess protect against osteoporosis?

  2001cited by this paper
• Effect of Sandostatin® LAR® on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity

  2001cited by this paper
• Cardiovascular Complications in Acromegaly: Methods of Assessment

  2001cited by this paper
• Altered circadian blood pressure profile in patients with active acromegaly. Relationship with left ventricular mass and hormonal values

  2001cited by this paper
• Risk factors for glucose intolerance in active acromegaly.

  2001influential reference
• The somatomedin hypothesis: 2001.

  2001cited by this paper
• Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.

  2001cited by this paper
• Insulin-like growth factor-I promotes proliferation and migration of cavernous smooth muscle cells.

  2001cited by this paper
• Ratios of IGF-I, IGF binding protein-3, and prostate-specific antigen in prostate cancer detection.

  2001cited by this paper
• Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly.

  2001influential reference
• Efficacy of radiotherapy in normalizing serum IGF‐I, acid‐labile subunit (ALS) and IGFBP‐3 levels in acromegaly

  2001cited by this paper
• Hypothalamic hormones and cancer.

  2001cited by this paper
• Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.

  2001cited by this paper
• Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly.

  2001cited by this paper
• CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem?

  2001cited by this paper
• Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

  2001cited by this paper
• Vascular function and blood pressure in GH transgenic mice.

  2001cited by this paper
• Relationship between blood pressure and glucose tolerance in acromegaly

  2001cited by this paper
• Reduction of lung distensibility in acromegaly after suppression of growth hormone hypersecretion.

  2001cited by this paper
• The atherogenic plasma remnant‐like particle cholesterol concentration is increased in the fasting and postprandial state in active acromegalic patients

  2001cited by this paper
• Risk of colorectal neoplasia in acromegaly: an independent view *

  2001cited by this paper
• Acromegaly and cancer: not a problem?

  2001influential reference
• The IGF system and breast cancer.

  2001cited by this paper
• Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient.

  2001cited by this paper
• Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist.

  2001cited by this paper
• Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.

  2001cited by this paper
• Demonstration of Direct Effects of Growth Hormone on Neonatal Cardiomyocytes*

  2001cited by this paper
• The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor.

  2001cited by this paper
• Increased arterial intima‐media thickness by B‐M mode echodoppler ultrasonography in acromegaly

  2001influential reference
• Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients

  2001cited by this paper
• Colonic transit influences deoxycholic acid kinetics.

  2001cited by this paper
• Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.

  2001cited by this paper
• Occurrence of ventricular late potentials in patients with active acromegaly

  2001influential reference
• Screening colonoscopy for acromegaly in perspective*

  2001influential reference
• Growth hormone and the heart

  2001influential reference
• Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.

  2001cited by this paper
• Clinical perspective: acromegaly and cancer: a problem.

  2001cited by this paper
• Expression of growth hormone-releasing factor, growth hormone, insulin-like growth factor-1 and its binding proteins in human lung.

  2000cited by this paper
• Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.

  2000influential reference
• Acute leukaemia in acromegaly patients

  2000cited by this paper
• Impaired β‐cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients

  2000influential reference
• Pituitary surgery for acromegaly.

  2000cited by this paper
• Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen.

  2000cited by this paper
• Conditional knockout of mouse insulin-like growth factor-1 gene using the Cre/loxP system.

  2000cited by this paper
• Criteria for cure of acromegaly: a consensus statement.

  2000cited by this paper
• Incidence of malignant tumors in patients with acromegaly.

  2000cited by this paper
• Cardiac effect of thyrotoxicosis in acromegaly.

  2000cited by this paper
• Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure.

  2000cited by this paper
• Exercise-induced microalbuminuria in patients with active acromegaly: acute effects of slow-release lanreotide, a long-acting somatostatin analog.

  2000cited by this paper

• ACROMEGALY: CURRENT MANAGEMENT AND THE EMERGING ROLE OF ORAL PALTUSOTINE

  2026cites this paper
• Diabetic Ketoacidosis as Presenting Feature of Acromegaly

  2026cites this paper
• Acromegaly: Diagnostic and Therapeutic Management Challenges in Senegal

  2026cites this paper
• Reappraisal of colorectal polyps in acromegaly: study on prevalence, recurrence and risk factors

  2026cites this paper
• Cancer Risk in Patients with Acromegaly: Insights from a Single Center in Ankara.

  2026cites this paper
• Rapid intraoperative boundary diagnosis of somatotroph pituitary neuroendocrine tumors using real-time PCR.

  2026cites this paper
• Clinical Evaluation of Sleep Disorders in Childhood: A Polysomnography-Based Study

  2026cites this paper
• Quality of life and psychological status in people with acromegaly in relation to disease-related facial changes

  2025cites this paper
• Acromegaly: Is earlier diagnosis possible? Exploration of a screening algorithm to select high-risk patients

  2025cites this paper
• High‐Density Lipoprotein Cholesterol Levels and the Risk of Acromegaly: A Nationwide Cohort Study

  2025cites this paper
• Headache characteristics in acromegaly: Only a secondary disorder?

  2025cites this paper
• Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly—A Preliminary Study

  2025cites this paper
• The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly

  2025cites this paper
• Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries

  2025cites this paper
• Cervical osteophyte complex causing compressive myelopathy leading to a diagnosis of acromegaly

  2025cites this paper
• A 62-Year-Old Man With New-Onset Hypertrophic Cardiomyopathy 25 Years After Surgical Remission of Acromegaly

  2025cites this paper
• Oral Health and Quality of Life in Acromegaly: A Questionnaire-Based Study

  2025cites this paper
• Determinants of QTc Interval Prolongation in Patients with Hypopituitarism and Other Pituitary Disorders

  2025cites this paper
• Case Report: Bilateral lens dislocation as an atypical presentation of acromegaly and review of the ocular effects of GH/IGF-1 excess

  2025cites this paper
• Static and Dynamic Balance Is Impaired in Patients With Long‐Term, Well‐Controlled Acromegaly: A Cross‐Sectional Study

  2025cites this paper
• Impact of pasireotide on lipid and glucose metabolism in patients with acromegaly: a systematic review and meta-analysis

  2025cites this paper
• Healthcare utilization and costs among patients with acromegaly in the United States

  2025cites this paper
• Long-Term Prognosis and Systemic Impact of Acromegaly: Analyses Utilizing Korean National Health Insurance Data

  2025influential citation
• Acromegaly

  2025cites this paper
• Acromegaly and the Risk of Cancer: A Nationwide Population-based Cohort Study in Korea.

  2025cites this paper
• Connecting Bone Remodeling and Regeneration: Unraveling Hormones and Signaling Pathways

  2025cites this paper
• Exploring Brain Parenchymal Changes in Acromegaly: Focus on White Matter Hyperintensities

  2025cites this paper
• Cardiomyopathy in patients with acromegaly - not truly a concern anymore?

  2025cites this paper
• Acromegaly.

  2025cites this paper
• Echocardiographic Findings in Cardiomyopathy Due to Acromegaly

  2025cites this paper
• From Subtle Signs to Severe Sequelae—A Century of Symptomatology and Comorbidities in the Diagnosis of GH-Secreting Pituitary Neuroendocrine Tumors: A Systematic Review

  2025cites this paper
• Development of lateral flow assay for quantitative analysis of growth hormone.

  2025cites this paper
• Evaluation of pituitary tumor volume as a prognostic factor in acromegaly: A cross-sectional study in two centers

  2025cites this paper
• Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) in Patients With Acromegaly in Colombia

  2025cites this paper
• Metabolic Factors Related to Interpersonal Dysfunction in Acromegaly: A Nationwide Cross‐Sectional Study in China

  2025cites this paper
• Impact of GH and IGF-I excess on nervous and vascular retinal structure in newly diagnosed acromegaly patients

  2025cites this paper
• The Effect of Visfatin Levels on Blood Pressure and Cardiac Risk Factors in Patients with Acromegaly

  2025cites this paper
• The Long-Term Effects of Postoperative Radiotherapy in Acromegaly: Results From a Single-Center Acromegaly Registry in Iran

  2025cites this paper
• The effect of first intervention on cardiac parameters in patients with acromegaly: a systematic review.

  2025cites this paper
• The Evaluation of Retinal, Choroidal, Scleral and Optic Disc Parameters in Acromegaly.

  2025cites this paper
• Assessment of the Left Ventricular Dysfunction in Patients With Acromegaly Using Global Longitudinal Strain by Two-Dimensional Speckle Tracking Echocardiography and Tissue Doppler Imaging

  2025cites this paper
• MRI morphometric analysis of anatomical structures affecting transsphenoidal surgery in acromegaly

  2025cites this paper
• Craniofacial parameters and obstructive sleep apnea in newly diagnosed acromegaly

  2025cites this paper
• Prevalence of neoplasms in acromegaly: a Turkish single-center retrospective study

  2025cites this paper
• Unveiling the invisible: Incidental Papillary thyroid carcinoma in a patient with acromegaly: A case report

  2025cites this paper
• Revisiting mortality in acromegaly using machine learning

  2025cites this paper
• ACROMEGALY – ETIOLOGY, SYMPTOMS, TREATMENT. LITERATURE REVIEW

  2025cites this paper
• The role of elevated monocyte and high-density lipoprotein cholesterol ratio in endothelial dysfunction and cardiovascular risk in acromegaly patients

  2025cites this paper
• Promising therapies for the treatment of acromegaly

  2025cites this paper
• Evaluation of fluid status in patients with acromegaly through bioelectrical impedance vector analysis: a cross-sectional study

  2025cites this paper
• Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults.

  2024cites this paper
• Thyroid Disorders in Saudi Patients With Acromegaly: A Tertiary Care Center Experience

  2024cites this paper
• The Heart’s Function as a Pump Assessed via Impedance Cardiography and the Autonomic System Balance in Patients with Early-Stage Acromegaly

  2024cites this paper
• ACROMORFO study: gait analysis in a cohort of acromegalic patients

  2024cites this paper
• Acromegaly: Overview and associated temporomandibular joint disorders

  2024cites this paper
• Shoulder osteoarthritis facilitating the diagnosis of acromegaly

  2024cites this paper
• Approach to the patient with controlled acromegaly and acromegalic arthropathy: clinical diagnosis and management

  2024influential citation
• Pituitary adenomas from the internist's perspective

  2024cites this paper
• REVIEW ARTICLE: CARDIOVASCULAR DISORDERS ASSOCIATED WITH ACROMEGALY: An Update.

  2024cites this paper
• Advantages of using T1-mapping in cardiac magnetic resonance imaging in patients with acromegaly

  2024cites this paper
• Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management

  2024cites this paper
• Assessment of the frequency and risk factors for colorectal cancer in acromegaly

  2024influential citation
• IGF-1 levels in the general population, heart failure patients, and individuals with acromegaly: differences and projections from meta-analyses—a dual perspective

  2024cites this paper
• Prevalence of Neoplasms in Patients with Acromegaly—A Single-Center Polish Study

  2024cites this paper
• Massive Pulmonary Embolism With Negative D-dimer: A Case Report

  2024cites this paper
• Electrocardiographic ventricular arrhythmia parameters during diagnosis and after the treatment of acromegaly: A case-control study

  2024cites this paper
• Time to first remission and survival in patients with acromegaly: Evidence from the UK Acromegaly Register Study (UKAR)

  2024cites this paper
• Acromegaly: Incidence, Patient Characteristics And Treatment Patterns In A 10-Year Nationwide Retrospective Hospital Cohort Study.

  2024cites this paper
• Serum phosphate levels at diagnosis predict long-term risk for hypopituitarism in patients with acromegaly

  2024cites this paper
• Investigating secondary hypertension in cerebrovascular disease

  2024cites this paper
• A Review on Coexisting Giants: The Interplay Between Acromegaly and Diabetes Mellitus

  2024cites this paper
• Acromegaly: diagnostic challenges and individualized treatment

  2024cites this paper
• Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management

  2024cites this paper
• Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery

  2024cites this paper
• Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

  2024cites this paper
• Cardiac MRI in acromegaly: looking for a big heart

  2024cites this paper
• Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly

  2024cites this paper
• The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study

  2024cites this paper
• Hydrogel-fiber-mesh-based 3D cell cultures: A new method for studying pituitary tumors

  2024cites this paper
• Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing’s disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study

  2024cites this paper
• Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly

  2024cites this paper
• Advancement in perioperative management of pituitary adenomas—Current concepts and best practices

  2024cites this paper
• Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades

  2024cites this paper
• Aortic root dilation in acromegaly

  2024cites this paper
• Severe myocardial hypertrophy and fibrosis in a patient with acromegaly: is the prevention of sudden cardiac death needed?

  2024cites this paper
• The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly

  2024cites this paper
• Childhood growth hormone treatment: challenges, opportunities, and considerations.

  2024cites this paper
• Changing faces: A case-based review of acromegaly

  2023cites this paper
• High prevalence of severe sleep cycle disruption in de novo acromegaly and underdiagnosis by common clinical screening tools: A prospective, observational, cross‐sectional study

  2023cites this paper
• Relationships among Development, Growth, Body Size, Reproduction, Aging, and Longevity – Trade-Offs and Pace-Of-Life

  2023cites this paper
• Assessment of osteoprotegerin and RANKL levels and several cardiovascular risk scoring systems in acromegaly

  2023cites this paper
• Endocrinologic Outcome Following Endonasal Transphenoidal Excision of Growth Hormone Secreting Pituitary Adenomas

  2023cites this paper
• Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk Factors.

  2023cites this paper
• Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly

  2023influential citation
• Adipocyte Subpopulations Mediate Growth Hormone Induced Lipolysis and Glucose Tolerance in Male Mice.

  2023cites this paper
• Discordant biochemical parameters of acromegaly remission do not influence the prevalence or aggressiveness of metabolic comorbidities: a single-center study

  2023cites this paper
• Corneal Parameters, Ocular Biometers, and Retinal and Choroidal Thickness in Acromegaly Patients.

  2023cites this paper
• Conventional X-rays in the diagnosis and follow-up of vertebral fractures in patients with acromegaly: a real-life study

  2023cites this paper
• The Socioeconomic Burden of Acromegaly.

  2023cites this paper
• Increase in intracellular and extracellular myocardial mass in patients with acromegaly: a cardiac magnetic resonance imaging study.

  2023cites this paper